ArticleJournal of multidisciplinary healthcare2024
Continuous Glucose Monitoring: A Transformative Approach to the Detection of Prediabetes.
Article in Journal of multidisciplinary healthcare, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of real-time continuous glucose monitoring on glycaemic control in adults with type 2 diabetes: systematic review and meta-analysis.Frontiers in endocrinology · 2025Pooled it
- Effect of a Personalized Mobile App on Glucose Control in Adults With Prediabetes and Type 2 Diabetes: Exploratory Pilot Randomized Controlled Trial.JMIR human factors · 2026Trial
- Beyond HbA1c: A CGM-centred three-pillar framework for glycaemic variability in pre-diabetes and type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2026Review
- Bridging the Continuous Glucose Monitoring decision gap: from glycaemic variability data to actionable stability in diabetes care.Frontiers in endocrinology · 2026Review
- The Impact of a Digital Peer-Supported App on Daily Steps and Lifestyle Changes Among Individuals With Prediabetes and Early-Stage Type 2 Diabetes: Prospective, Nonrandomized Controlled Trial.JMIR formative research · 2025Article
- Continuous glucose monitoring in Korean pediatric patients with type 1 diabetes: current landscape and clinical implications.Clinical and experimental pediatrics · 2025Article
- Review
- Personalized therapeutic approaches for improved glycemic outcomes in type 2 diabetes.World journal of diabetes · 2025Article
- Postprandial Glucose: A Variable in Continuum.Clinical medicine insights. Endocrinology and diabetes · 2025Review
- Oral Health and Diabetic Cardiomyopathy: Mechanisms, Biomarkers, and Early Screening Approaches.Journal of inflammation research · 2025Article
- Federated multimodal AI for precision-equitable diabetes care.Frontiers in digital health · 2025Review
- Continuous glucose monitoring combined with artificial intelligence: redefining the pathway for prediabetes management.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prediabetes, as an intermediary stage between normal glucose homeostasis and overt diabetes, affects an estimated 720 million individuals worldwide, highlighting the urgent need for proactive intervention strategies. Continuous glucose monitoring (CGM) emerges as a transformative tool, offering unprecedented insights into glycemic dynamics and facilitating tailored therapeutic interventions. This perspective scores the clinical significance of even slightly elevated fasting blood glucose levels and the critical role of early intervention. CGM technology provides real-time, continuous data on glucose concentrations, surpassing the constraints of conventional monitoring methods. Both retrospectively analyzed and real-time CGM systems offer valuable tools for glycemic management, each with unique strengths. The integration of CGM into routine care can detect early indicators of type 2 diabetes, inform the development of personalized intervention strategies, and foster patient engagement and empowerment. Despite challenges such as cost and the need for effective utilization through training and education, CGM's potential to revolutionize prediabetes management is evident. Future research should focus on refining CGM algorithms, exploring personalized intervention strategies, and leveraging wearable technology and artificial intelligence advancements to optimize glycemic control and patient well-being.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.